Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - Other
Ratios

Perspective Therapeutics (CATX) Leases (2019 - 2025)

Perspective Therapeutics' Leases history spans 9 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Leases fell 36.87% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, down 36.87%, while the annual FY2024 figure was $2.2 million, 196.52% up from the prior year.
  • Leases for Q3 2025 was $1.5 million at Perspective Therapeutics, down from $1.8 million in the prior quarter.
  • Across five years, Leases topped out at $2.4 million in Q3 2024 and bottomed at $309000.0 in Q1 2023.
  • The 5-year median for Leases is $817500.0 (2021), against an average of $1.2 million.
  • The largest YoY upside for Leases was 243.6% in 2023 against a maximum downside of 46.45% in 2023.
  • A 5-year view of Leases shows it stood at $642000.0 in 2021, then plummeted by 30.69% to $445000.0 in 2022, then soared by 67.87% to $747000.0 in 2023, then surged by 196.52% to $2.2 million in 2024, then crashed by 30.65% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Leases are $1.5 million (Q3 2025), $1.8 million (Q2 2025), and $2.0 million (Q1 2025).